These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 19744038)

  • 1. Robust detection of EGFR copy number changes and EGFR variant III: technical aspects and relevance for glioma diagnostics.
    Jeuken J; Sijben A; Alenda C; Rijntjes J; Dekkers M; Boots-Sprenger S; McLendon R; Wesseling P
    Brain Pathol; 2009 Oct; 19(4):661-71. PubMed ID: 19744038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes as a biomarker platform for detecting epidermal growth factor receptor-positive high-grade gliomas.
    Manda SV; Kataria Y; Tatireddy BR; Ramakrishnan B; Ratnam BG; Lath R; Ranjan A; Ray A
    J Neurosurg; 2018 Apr; 128(4):1091-1101. PubMed ID: 28574310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathologic diagnosis of epidermal growth factor receptor.
    Maire CL; Ligon KL
    Neuro Oncol; 2014 Oct; 16 Suppl 8(Suppl 8):viii1-6. PubMed ID: 25342599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.
    Liu L; Bäcklund LM; Nilsson BR; Grandér D; Ichimura K; Goike HM; Collins VP
    J Mol Med (Berl); 2005 Nov; 83(11):917-26. PubMed ID: 16133418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous detection of EGFR amplification and EGFRvIII variant using digital PCR-based method in glioblastoma.
    Fontanilles M; Marguet F; Ruminy P; Basset C; Noel A; Beaussire L; Viennot M; Viailly PJ; Cassinari K; Chambon P; Richard D; Alexandru C; Tennevet I; Langlois O; Di Fiore F; Laquerrière A; Clatot F; Sarafan-Vasseur N
    Acta Neuropathol Commun; 2020 Apr; 8(1):52. PubMed ID: 32303258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific and sensitive hydrolysis probe-based real-time PCR detection of epidermal growth factor receptor variant III in oral squamous cell carcinoma.
    McIntyre JB; Bose P; Klimowicz AC; Brockton NT; Petrillo S; Matthews W; Easaw J; Magliocco A; Dort JC
    PLoS One; 2012; 7(2):e31723. PubMed ID: 22359620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early experience with formalin-fixed paraffin-embedded (FFPE) based commercial clinical genomic profiling of gliomas-robust and informative with caveats.
    Movassaghi M; Shabihkhani M; Hojat SA; Williams RR; Chung LK; Im K; Lucey GM; Wei B; Mareninov S; Wang MW; Ng DW; Tashjian RS; Magaki S; Perez-Rosendahl M; Yang I; Khanlou N; Vinters HV; Liau LM; Nghiemphu PL; Lai A; Cloughesy TF; Yong WH
    Exp Mol Pathol; 2017 Aug; 103(1):87-93. PubMed ID: 28663030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiplex ligation-dependent probe amplification: a diagnostic tool for simultaneous identification of different genetic markers in glial tumors.
    Jeuken J; Cornelissen S; Boots-Sprenger S; Gijsen S; Wesseling P
    J Mol Diagn; 2006 Sep; 8(4):433-43. PubMed ID: 16931583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predominant expression of mutant EGFR (EGFRvIII) is rare in primary glioblastomas.
    Biernat W; Huang H; Yokoo H; Kleihues P; Ohgaki H
    Brain Pathol; 2004 Apr; 14(2):131-6. PubMed ID: 15193025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy.
    Marquez A; Wu R; Zhao J; Tao J; Shi Z
    Diagn Mol Pathol; 2004 Mar; 13(1):1-8. PubMed ID: 15163002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of intragenic receptor tyrosine kinase deletions in primary glioblastomas: their prevalence and molecular correlates.
    Kastenhuber ER; Huse JT; Berman SH; Pedraza A; Zhang J; Suehara Y; Viale A; Cavatore M; Heguy A; Szerlip N; Ladanyi M; Brennan CW
    Acta Neuropathol; 2014 May; 127(5):747-59. PubMed ID: 24292886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and prognostic significance of the epidermal growth factor receptor vIII mutation in glioblastoma patients treated with concurrent and adjuvant temozolomide radiochemotherapy.
    Weller M; Kaulich K; Hentschel B; Felsberg J; Gramatzki D; Pietsch T; Simon M; Westphal M; Schackert G; Tonn JC; von Deimling A; Davis T; Weiss WA; Loeffler M; Reifenberger G;
    Int J Cancer; 2014 May; 134(10):2437-47. PubMed ID: 24614983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor gene expression in high grade gliomas.
    Larysz D; Kula D; Kowal M; Rudnik A; Jarząb M; Blamek S; Bierzyńska-Macyszyn G; Kowalska M; Bażowski P; Jarząb B
    Folia Neuropathol; 2011; 49(1):28-38. PubMed ID: 21455841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of glioblastoma harboring non-amplified epidermal growth factor receptor variant III: Critical molecular detection using RNA-based panel analysis.
    Kirishima M; Akahane T; Takajo T; Higa N; Yonezawa H; Uchida H; Kamimura K; Hanaya R; Yoshimoto K; Higashi M; Yoshiura T; Tanimoto A
    Pathol Res Pract; 2023 Aug; 248():154712. PubMed ID: 37499520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain.
    Guillaudeau A; Durand K; Rabinovitch-Chable H; Pommepuy I; Mesturoux L; Robert S; Chaunavel A; Moreau JJ; Labrousse F
    Int J Oncol; 2012 Apr; 40(4):1142-52. PubMed ID: 22159595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly Sensitive EGFRvIII Detection in Circulating Extracellular Vesicle RNA of Glioma Patients.
    Batool SM; Muralidharan K; Hsia T; Falotico S; Gamblin AS; Rosenfeld YB; Khanna SK; Balaj L; Carter BS
    Clin Cancer Res; 2022 Sep; 28(18):4070-4082. PubMed ID: 35849415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financially effective test algorithm to identify an aggressive, EGFR-amplified variant of IDH-wildtype, lower-grade diffuse glioma.
    Bale TA; Jordan JT; Rapalino O; Ramamurthy N; Jessop N; DeWitt JC; Nardi V; Alvarez MM; Frosch M; Batchelor TT; Louis DN; Iafrate AJ; Cahill DP; Lennerz JK
    Neuro Oncol; 2019 May; 21(5):596-605. PubMed ID: 30496526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a real-time RT-PCR assay for detecting EGFRvIII in glioblastoma samples.
    Yoshimoto K; Dang J; Zhu S; Nathanson D; Huang T; Dumont R; Seligson DB; Yong WH; Xiong Z; Rao N; Winther H; Chakravarti A; Bigner DD; Mellinghoff IK; Horvath S; Cavenee WK; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2008 Jan; 14(2):488-93. PubMed ID: 18223223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma.
    Tykocinski ES; Grant RA; Kapoor GS; Krejza J; Bohman LE; Gocke TA; Chawla S; Halpern CH; Lopinto J; Melhem ER; O'Rourke DM
    Neuro Oncol; 2012 May; 14(5):613-23. PubMed ID: 22492960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens.
    Feldkamp MM; Lala P; Lau N; Roncari L; Guha A
    Neurosurgery; 1999 Dec; 45(6):1442-53. PubMed ID: 10598712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.